antimony has been researched along with Cancer of Pelvis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arnaud, D; Dilhuydy, JM; Ducassou, D; Vilayleck, S | 1 |
| Ferrier, D; Kloiber, R | 1 |
1 trial(s) available for antimony and Cancer of Pelvis
| Article | Year |
|---|---|
[Radioisotopic lymphography by an indirect route of the abdomino-pelvic lymphatic chains. Value of antimony sulfocolloid labelled with technetium 99m (author's transl)].
Topics: Abdominal Neoplasms; Antimony; Clinical Trials as Topic; Colloids; Humans; Lymphatic Metastasis; Pelvic Neoplasms; Povidone; Radionuclide Imaging; Sulfides; Technetium | 1975 |
1 other study(ies) available for antimony and Cancer of Pelvis
| Article | Year |
|---|---|
Iliopelvic lymphoscintigraphy as a predictor of early metastatic disease in patients with prostate carcinoma.
Topics: Aged; Antimony; Colloids; Humans; Lymphatic Metastasis; Male; Middle Aged; Pelvic Neoplasms; Prostatic Neoplasms; Radionuclide Imaging; Technetium; Technetium Compounds; Time Factors | 1992 |